COVID-19 Vaccine Candidate Heads To Widespread Testing In U.S.

A COVID-19 vaccine candidate developed by the U.S. company Moderna and the National Institutes of Health starts its final phase of testing. It's one of a handful of candidates to reach this stage.(Image credit: Maddie Meyer/Getty Images)

Source: NPR Health and Science - July 27, 2020 Category: Consumer Health News Authors: Joe Palca Source Type: news